These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9690302)

  • 1. [The TNM classification. Critical review].
    Appere de Vecchi C; Brechot JM; Lebeau B
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):323-32. PubMed ID: 9690302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
    Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new tumor, node, and metastasis staging system.
    Rami-Porta R; Bolejack V; Goldstraw P
    Semin Respir Crit Care Med; 2011 Feb; 32(1):44-51. PubMed ID: 21500123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controversy over the UICC-TNM classification].
    Tsuchiya R
    Nihon Geka Gakkai Zasshi; 2001 Jul; 102(7):502-6. PubMed ID: 11505500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new TNM classification in lung cancer].
    Wrona A; Jassem J
    Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The international TNM classification of bronchopulmonary cancer].
    Bercea O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):193-202. PubMed ID: 2855663
    [No Abstract]   [Full Text] [Related]  

  • 11. TNM classification for lung cancer.
    Watanabe Y
    Ann Thorac Cardiovasc Surg; 2003 Dec; 9(6):343-50. PubMed ID: 15003094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of T3 (T4) in the TNM classification of lung cancer].
    Heinzer FC
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1470-4. PubMed ID: 3672083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Justification of the TNM classification system in lung carcinoma].
    Baumann HR
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1466-9. PubMed ID: 3672082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the new TNM classification for resected lung cancer].
    Miyazawa M; Shiina T; Kurai M; Makiuchi A; Numanami H; Kondo R; Takasuna K; Machida E; Hanaoka T; Yoshida K; Kaneko K; Yamanda T; Haniuda M; Amano J
    Kyobu Geka; 2000 Oct; 53(11):915-8. PubMed ID: 11048441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.
    Travis WD;
    Histopathology; 2009 Jan; 54(1):3-11. PubMed ID: 19187176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.